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Rat Forebrain Neurogenesis and Striatal
Neuron Replacement after Focal Stroke
Jack M. Parent, MD,1 Zinaida S. Vexler, PhD,2,3 Chao Gong, MD, PhD,1 Nikita Derugin, MA,4
and Donna M. Ferriero, MD2,3
The persistence of neurogenesis in the forebrain subventricular zone (SVZ) of adult mammals suggests that the mature
brain maintains the potential for neuronal replacement after injury. We examined whether focal ischemic injury in adult
rat would increase SVZ neurogenesis and direct migration and neuronal differentiation of endogenous precursors in
damaged regions. Focal stroke was induced in adult rats by 90-minute right middle cerebral artery occlusion (tMCAO).
Cell proliferation and neurogenesis were assessed with bromodeoxyuridine (BrdU) labeling and immunostaining for cell
type-specific markers. Brains examined 10–21 days after stroke showed markedly increased SVZ neurogenesis and chains
of neuroblasts extending from the SVZ to the peri-infarct striatum. Many BrdU-labeled cells persisted in the striatum and
cortex adjacent to infarcts, but at 35 days after tMCAO only BrdU-labeled cells in the neostriatum expressed neuronal
markers. Newly generated cells in the injured neostriatum expressed markers of medium spiny neurons, which charac-
terize most neostriatal neurons lost after tMCAO. These findings indicate that focal ischemic injury increases SVZ
neurogenesis and directs neuroblast migration to sites of damage. Moreover, neuroblasts in the injured neostriatum
appear to differentiate into a region-appropriate phenotype, which suggests that the mature brain is capable of replacing
some neurons lost after ischemic injury.
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The forebrain subventricular zone (SVZ) of adult rodents
is a persistent germinative zone that generates olfactory
bulb neurons throughout life.1–4 The neuronal precursors
in the SVZ undergo a long-distance tangential migration
to the olfactory bulb in a restricted pathway known as the
rostral migratory stream (RMS).3 SVZ neuroblasts mi-
grate along one another in chains within the RMS, and
the chains are surrounded by astrocytic, tube-like struc-
tures.3–5 The immature neurons also express characteristic
markers, such as the polysialylated form of neural cell ad-
hesion molecule (PSA-NCAM)4,6,7 and doublecortin
(DCx),8,9 as they proliferate and migrate. Similar neuro-
genic pathways also may persist in adult primates.10–12
The presence of neurogenesis in the adult mammalian
forebrain raises the possibility that endogenous neural pre-
cursor cells could contribute to neuronal replacement after
injury.13,14
Recent studies indicate that acute brain injury influ-
ences neuronal precursor behavior in the adult rodent
forebrain SVZ. Various types of injury, such as aspira-
tion or transection lesions of cortex, inflammatory or
chemical demyelination, or percussion trauma, increase
SVZ precursor proliferation in the adult rodent fore-
brain.15–20 The fate of the SVZ neural precursors has
been characterized after chemical demyelination and per-
cussion trauma, and in these settings the newly gener-
ated cells differentiate into glia.18,20 In contrast, work by
Fallon and colleagues showed that precursors arising
from the SVZ generate neurons in the adult rat striatum
after a combination of 6-hydroxydopamine lesions of
substantia nigra and striatal transforming growth fac-
tor– infusions.21 We recently found that forebrain
SVZ neurogenesis also increases after chemoconvulsant-
induced status epilepticus, and that a portion of the neu-
roblasts destined for the olfactory bulb exit the RMS
prematurely and migrate into the injured forebrain.22
2To better understand the influence of brain injury
on adult forebrain SVZ neuroblasts and the potential for
neuronal replacement after stroke, we examined the ef-
fects of focal ischemic injury on SVZ neurogenesis. Fo-
cal or global cerebral ischemia has been shown to in-
crease neurogenesis in the hippocampal dentate
gyrus,23–25 another region of persistent neurogenesis26 in
the adult mammalian brain. Zhang and colleagues re-
cently found increased numbers of newly generated cells
in the SVZ and olfactory bulb after injury in an adult
rat model of embolic middle cerebral artery (MCA) oc-
clusion. We induced focal infarcts in adult rats using the
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transient MCA suture occlusion (tMCAO) stroke
model, and then examined SVZ cell proliferation and
the phenotypes of newly generated cells in periinfarct re-
gions by 5-bromodeoxyuridine (BrdU) labeling and im-
munohistochemistry for cell type–specific markers. Our
findings indicate that focal ischemia in the adult rat in-
creases forebrain SVZ neurogenesis and leads to the gen-
eration of new neurons with appropriate regional speci-
ficity in the periinfarct neostriatum.
Materials and Methods
Transient Middle Cerebral Artery Suture
Occlusion Procedure
Adult (190–260gm) male Sprague-Dawley rats (Harlan, Indi-
anapolis, IN) were used for all experiments. The protocols
were approved by the committees on animal research of the
University of California, San Francisco and the University of
Michigan. Rats were anesthetized initially in a chamber with
4% isoflurane in a 70% to 30% mixture of N2O to O2,
and the isoflurane was decreased to 1.5 to 1.75% after induc-
tion. tMCAO was produced for 90 minutes as described
previously.27 No blood loss occurred during occlusion or
reperfusion. Sham-operated controls were anesthetized in an
identical manner and underwent midline cervical incision
without perturbation of the carotid arteries.
A total of 33 animals underwent tMCAO and 3 had sham
surgery. The 3 controls and 18 rats in the tMCAO group
were anesthetized with isoflurane as described above; 15 an-
imals (including 4 used for quantification studies, see below)
were anesthetized with ketamine (80mg/kg) and xylazine
(12mg/kg). Survival and range of infarct sizes were similar
with both anesthetics. Infarcts involved both striatum and
cortex in 19 of 33 rats, and only these samples were used for
quantitative analyses (see below). The remainder of the ani-
mals had no lesion or a small, focal lesion restricted to the
striatum. None had only cortical lesions.
5-Bromodeoxyuridine Labeling and Tissue Processing
The thymidine analog BrdU (Boehringer Mannheim, India-
napolis, IN) was used to label S-phase cells.28 Rats received
two BrdU injections (50mg/kg IP in phosphate-buffered sa-
line), 6 hours apart, on days 7 to 9 after tMCAO for a total of
six injections. This time point was chosen based on prior stud-
ies showing maximal increases in SVZ cell proliferation at 7
days after prolonged seizures or focal ischemia,22,26 and also to
limit the labeling of proliferating glial cells in the early period
after brain injury. Animals used for immunofluorescence and
quantitative analyses were killed 10 (n  5), 14 (n  4), 21
(n  3), or 35 (n  4) days after tMCAO (days 1, 5, 12, or
26 after the last BrdU injection). Additional animals were
killed at 21- and 35-day time points and used for immuno-
fluorescence double labeling. Sham-operated controls received
identical BrdU injections and were killed 14 days after
tMCAO (n  3). Rats were killed by an overdose of pento-
barbital sodium (Abbott Laboratories, North Chicago, IL) and
were transcardially perfused with phosphate-buffered saline
followed by 4% paraformaldehyde in phosphate-buffered sa-
line (360ml; pH 7.4). Brains were postfixed overnight, cryo-
protected, frozen, and microtome-sectioned coronally through
the striatal SVZ, RMS, and olfactory bulb at 40m. Every
sixth section was processed for Nissl stain and immunohisto-
chemistry as described below.
Nissl Stain and Peroxidase Immunohistochemistry
Sections were Nissl stained according to standard methods.22
Diaminobenzidine peroxidase immunohistochemistry was per-
formed on free-floating sections as described previously.29,30
To label proliferating cells, we used primary antibodies that
recognize BrdU (mouse monoclonal; 1:1,000; Boehringer
Mannheim) and cdc2 (mouse monoclonal; 1:1,000; Santa
Cruz Biotechnology, Santa Cruz, CA). Cdc2 (p34cdc2) is a cell
cycle–related kinase expressed by proliferating cells in the adult
rodent SVZ.31 Migrating neuroblasts were identified using an
antibody to DCx (rabbit polyclonal; 1:2,000; a gift from C.
Walsh, Harvard University), a microtubule-associated protein
expressed by SVZ neuroblasts.8 For some experiments, we
used a DCx antibody that we generated using the same pro-
tocol (Covance, Richmond, CA).8 Both DCx antibodies
showed identical patterns of immunolabeling using both per-
oxidase and fluorescence immunohistochemistry. For BrdU
immunostaining, DNA was first denatured by incubating tis-
sue sections in 2N HCl for 30 minutes at 37°C followed by a
10-minute wash in 0.1M borate solution, pH 8.5.
Immunofluorescence Histochemistry and
Confocal Microscopy
Single and double-label immunofluorescence histochemistry
was performed on free-floating sections according to previ-
ously described methods.29,30 Primary antibody dilutions
used were 1:200 for BrdU (rat monoclonal; Accurate Chem-
ical, Westbury, NY); 1:1,000 for PSA-NCAM (mouse IgM
5A5 clone; Developmental Hybridoma Bank, University of
Iowa); 1:1,000 for DCx; 1:200 for glial fibrillary acidic pro-
tein (GFAP; rat monoclonal; a gift from V. Lee, University
of Pennsylvania), or 1:500 for GFAP (rabbit polyclonal;
Sigma, St. Louis, MO); 1:200 for vimentin (mouse mono-
clonal; DAKO, Carpinteria, CA); 1:1,000 for myelin oligo-
dendrocyte glycoprotein (MOG; mouse monoclonal, a gift
from C. Bernard, Melbourne, Australia); 1:200 for ED1
(mouse monoclonal, Serotec, Oxford, UK); 1:500 for glucose
transporter-1 (Glut-1; rabbit polyclonal; Chemicon, Te-
mecula, CA); 1:1,000 for NeuN (mouse monoclonal,
Chemicon); 1:8,000 for DARPP-32 (a gift from P. Geen-
gard, Rockefeller Institute, New York); 1:500 for calbindin
D28k (mouse monoclonal; Sigma); and 1:400 for class III
-tubulin (TuJ1 clone, mouse monoclonal; Covance). Sec-
ondary antibodies used for immunofluorescence were goat
anti–rat IgG conjugated to fluorescein isothiocyanate (FITC)
or Alexa 594 (1:800; Molecular Probes, Eugene, OR), goat
anti–mouse IgG conjugated to FITC or Texas Red, goat
anti–rabbit IgG conjugated to FITC or Alexa 594, and goat
anti–mouse IgM conjugated to FITC or Texas Red (except
as noted, all secondary antibodies were used at 1:400 dilu-
tions, and were species cross-adsorbed from Jackson Immu-
noresearch Laboratories, West Grove, PA).
For double-label immunofluorescence using rat anti-BrdU
and a second primary antibody, free-floating sections were
first incubated in the second primary antibody for 24 hours
at 4°C, washed for 45 minutes, postfixed in 4% paraformal-
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dehyde for 20 minutes, and denatured as described above.
After incubation in blocking solution, sections were incu-
bated in rat anti-BrdU and the second primary antibody for
another 24 hours at 4°C. Images were obtained using a Bio-
Rad MRC 1024 (Hercules, CA) or Zeiss LSM 510
(Oberkochen, Germany) confocal laser microscope as single
optical images or z-series stacks of 0.8 to 1m slice thick-
ness. Images were transferred to Adobe Photoshop (Adobe
Systems, Mountain View, CA) for color merging.
Data Quantification and Analysis
For quantification of Nissl staining and cdc2, DCx, or BrdU
immunostaining, images were digitally captured using a Nikon
Microphot-SA (Melville, NY) or Leica DMIRB (Heidelberg,
Germany) microscope under a 10 objective and attached to
a JVC (Yokohama, Japan) or SPOT-RT (SPOT Diagnostic
Instruments, Sterling Heights, MI) digital camera. Images
were imported into NIH image 1.61 for blinded densitometric
analysis. Regions of interest were drawn manually over the
SVZ or adjacent neostriatum (see Fig 1A). Measurements in
the regions of interest were made from three to five sections
per animal in NIH image using a threshold cutoff of four
standard deviations above background grayscale levels. Statis-
tical comparisons between ipsilateral and contralateral hemi-
spheres were made using paired t tests, and between tMCAO
and sham-surgery groups using two-tailed Student’s t tests,
both with StatView software (Abacus Concepts, Berkeley,
CA). Counts of BrdU- and double-labeled cells in the in-
farcted neostriatum were made using confocal z-series stacks
obtained from three to five randomly chosen microscopic
fields under a 63 water objective. The stacks were carefully
analyzed to ensure colocalization of signal within individual
cells and the exclusion of “satellite” cells.32
Results
Increased Cell Proliferation and Expansion of the
Subventricular Zone after Occlusion of the Right
Middle Cerebral Artery
As described previously,27 90-minute tMCAO in adult
rats typically resulted in large infarcts involving the ip-
silateral striatum and neocortex at the level of the stri-
atal SVZ (see Fig 1B). We first sought to determine
whether focal ischemic injury increases SVZ cell pro-
liferation. Brain sections were immunostained for the
cell cycle antigen cdc2 (p34cdc2), which is expressed by
proliferating SVZ cells,31 between 10 and 35 days after
tMCAO. Compared with the contralateral hemisphere,
cdc2 immunoreactivity increased significantly ipsilat-
eral to the stroke at 14 days after tMCAO (Figs 2A, B
and 3), and trended toward increases at 10 and 21 days
(p  0.1 for each, paired t test). The increase in cdc2
immunoreactivity ipsilateral to the stroke predomi-
nated in the dorsolateral SVZ in which the highest
numbers of proliferating cells are normally found.22,31
By 35 days after tMCAO, ipsilateral SVZ structure was
distorted (see Fig 2C and J), making quantitative com-
parison with the contralateral side difficult. We also
determined interhemispheric differences in SVZ cell
proliferation of stroke animals versus sham-operated
controls killed at the 14 day time point. The ratio of
ipsilateral to contralateral SVZ cdc2 immunostaining
was significantly greater after ischemia (tMCAO group
ratio 2.06 vs control ratio 1.48; p  0.05, two-tailed t
test). To confirm the stroke-induced increase in SVZ
cell proliferation, we administered BrdU on days 7 to 9
after tMCAO, killed animals 24 hours after the last
injection and examined BrdU labeling by immunohis-
tochemistry. In the contralateral hemisphere, BrdU la-
beling was largely confined to the SVZ (see Fig 2D).
On the side of the stroke, however, BrdU labeling was
increased in the SVZ, and labeled cells also were found
in the adjacent neostriatum (see Fig 2E). Quantifica-
tion of BrdU labeling at 10 days after tMCAO showed
significant increases of 18 and 460% in the ipsilateral
SVZ and striatum, respectively, compared with the
contralateral hemisphere (see Fig 3).
We next used Nissl staining to determine whether
the increase in cell proliferation ipsilateral to the infarct
led to an expansion of the SVZ. As expected, the dor-
solateral SVZ of the infarcted hemisphere enlarged
within 2 weeks after tMCAO compared with the con-
tralateral side and to sham-operated controls at both
rostral (see Fig 1B) and more caudal (see Fig 2F–J)
SVZ levels. SVZ Nissl staining was increased signifi-
cantly at 14 and 21 days after tMCAO (see Fig 3). No
qualitative change was seen in the cell density of the
SVZ of either hemisphere after focal ischemia at these
time points. As was the case for cdc2, the interhemi-
spheric ratio of SVZ cresyl violet–stained area was
greater after tMCAO compared with sham-operated
controls (tMCAO group ratio 1.46 vs control ratio
1.09, p  0.05, two-tailed t test). The increase in mi-
totic activity identified by BrdU and cdc2 immuno-
Fig 1. Schematic diagram of the striatal subventricular zone
(SVZ) with areas used for quantification, and an example of a
stroke in an adult rat 2 weeks after 90-minute occlusion of the
right middle cerebral artery (tMCAO) (A) Diagram of a coro-
nal view at the level of the striatal SVZ. Boxed areas show the
regions of interest for measurements in the dorsolateral SVZ (a)
and neostriatum (b). LV  lateral ventricle; Str  striatum;
Cx  cortex. (B) Nissl-stained, coronal section through the ros-
tral SVZ of an adult rat 2 weeks after tMCAO. Note the large
infarct (asterisk) and the larger size of the dorolateral SVZ ipsi-
lateral to the stroke (arrows). Scale bar  300m.
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staining (within 10–14 days) preceded the maximal ex-
pansion of the SVZ (within 14–21 days after tMCAO
by Nissl stain), suggesting that the SVZ cells accumu-
lated because of either accelerated proliferation or fail-
ure of migration out of the SVZ. However, BrdU-
labeled cells were found in the olfactory bulbs of both
Fig 3. Quantification of cell proliferation and subventricular zone (SVZ) size at different time points after occlusion of the right
middle cerebral artery (tMCAO). The mean area of immunoreactivity (for 5-bromodeoxyuridine [BrdU], cdc2, or DCx) or Nissl
staining (CV) in the ipsilateral (i) SVZ or neostriatum (Stm) relative to the contralateral (c) hemisphere is shown. All measure-
ments are of the SVZ except for the second pair (10 d Stm BrdU). Single asterisk, p  0.05, double asterisk, p  0.01 (paired t
test). N  3 to 5 per group. Error bars are SEM.
Fig 2. Coronal sections of the dorsal half of the striatal subventricular zone (SVZ) show increased cell proliferation and an enlarged
SVZ after focal ischemia. (A, B) Immunoreactivity for the endogenous cell proliferation marker cdc2 is increased in the dorsolateral
SVZ of the infarcted hemisphere (B) 2 weeks after occlusion of the right middle cerebral artery (tMCAO) compared with the con-
tralateral (cl) hemisphere (A), especially in the infracallosal tail of the SVZ (arrows in A, B). (C) cdc2 immunostaining 35 days
after tMCAO shows loss of the infracallosal tail (asterisk) and some labeling in the adjacent neostriatum. (D, E) Increased 5-
bromodeoxyuridine immunoreactivity 10 days after tMCAO in the SVZ, striatum, and corpus callosum ipsilateral to the stroke (E)
compared with contralateral (D). (F, G) Cresyl violet staining shows an expanded dorsolateral SVZ in the injured hemisphere 14
to 35 days after tMCAO (H–J) compared with contralateral (G) or a sham-operated control (F). At 35 days after ischemia (J), the
infracallosal tail is lost and the dorsolateral SVZ extends into the neostriatum (asterisk in J). Scale bar (in E)  100m. cl 
contralateral; il  ipsilateral.
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Fig 4. Subventricular zone (SVZ) doublecortin immunoreactivity after focal ischemia. (A, B) DCx immunoreactivity in the ipsilat-
eral SVZ and striatum (B) is markedly increased compared with contralateral (A) in an adult rat 2 weeks after occlusion of the
right middle cerebral artery (tMCAO). Asterisks in B denote the border of the infarct. (C–E) Higher magnification images of the
boxed areas in B show labeled cells with migratory morphology in periinfarct cortex (C, arrows), and in the neostriatum in clusters
(D) or chains (E, arrows). (F, G) DCx immunoreactivity restricted to the inferior aspect of the ipsilateral SVZ of a different ani-
mal 2 weeks after focal ischemia. The asterisk in G marks the inferior tip of the lateral ventricle. (H–J) Confocal images of a
DCx-immunostained coronal section through the striatal SVZ from an adult rat 3 weeks after tMCAO. (J) Higher magnification
of the boxed area in I shows DCx-positive neuroblasts extending in chains from the SVZ to the injured neostriatum. Scale bar in
J  250m for A, B; 30m for C to E; 100m for F to I; and 20m for J. il  ipsilateral; cl  contralateral.
Fig 5. Confocal immunofluorescence double labeling shows increased neuroblast numbers in the subventricular zone (SVZ) and
neostriatum after focal stroke. (A, B) DCx-labeled cells in the SVZ 14 days after occlusion of the right middle cerebral artery
(tMCAO) coexpress neuron-specific -tubulin but not glial fibrillary acidic protein. (C) The neuroblasts also express PSA-NCAM
(green) and many incorporated 5-bromodeoxyuridine (BrdU; red) given 5 to 7 days earlier. (D–E) Double labeling for PSA-
NCAM (red) and vimentin (green) 21 days after tMCAO. The inset in E is a higher magnification view of the boxed area. PSA-
NCAM immunoreactivity extends from the dorsolateral SVZ into the injured neostriatum (asterisk in E). (F) A higher magnifica-
tion image from this region. Chains of PSA-NCAM–labeled cells (arrowheads; red) are adjacent to vimentin-immunoreactive
astrocytes (green). Similar chains are seen with DCx immunostaining (arrowheads in K). (G–J) Double labeling for BrdU (red)
and DCx (green in H), PSA-NCAM (green in I), or MAP2 (green in G, J) in the ipsilateral neostriatum 14 days after tMCAO.
The cells in H to J are near the infarct boundary at approximately the boxed area in G. Arrows point to double-labeled cells.
(K–M) DCx-expressing cells (green) in the ipsilateral neostriatum 14 days after focal ischemia coexpress MAP2 (red in M) but not
vimentin (red in K) or the oligodendrocyte protein MOG (red in H). Scale bar in M  75m for A to C; 100m for D, E;
125m for G; and 25m for inset in E and F and H to L.
‹
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hemispheres at 2 to 3 weeks after tMCAO (data not
shown), indicating that migration in the SVZ–olfac-
tory bulb pathway was not impeded by the stroke.
Nissl staining 5 weeks after tMCAO showed a distor-
tion of the dorsolateral SVZ structure in the infarcted
hemisphere. The dorsolateral, infracallosal tail was lost
and extended inferolaterally toward the injured neostria-
tum (see Fig 2J). Although cell proliferation and Nissl
staining in the ipsilateral SVZ consistently increased after
large infarcts involving both striatum and cortex, smaller
Figure 5
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ischemic injury limited to the striatum produced a smaller
and more variable effect. Examination of cdc2 expression,
BrdU labeling and Nissl staining in the proximal RMS
showed a similar expansion ipsilateral to the infarct (data
not shown), although this change was seen in only a few
animals in which the infarct extended rostrally to RMS
levels. Taken together, these data indicate that focal isch-
emic injury increases SVZ precursor proliferation and ex-
pands the forebrain SVZ.
Occlusion of the Right Middle Cerebral Artery
Increases Neurogenesis in the Forebrain
Subventricular Zone
To determine whether the stroke-induced SVZ expan-
sion resulted from increased numbers of immature neu-
rons, we examined the patterns of immunostaining for
markers selectively expressed by SVZ neuroblasts. First,
the expression of DCx, a microtubule-associated protein
present in migrating neuronal precursors,8,22 was exam-
ined after tMCAO. SVZ DCx immunoreactivity ap-
peared greater in the SVZ ipsilateral to the stroke at all
time points examined (Fig 4A, B, H, I). Quantification
of DCx immunostaining in the SVZ at 14 days after
tMCAO showed a significant increase ipsilateral to the
stroke (see Fig 3). As described for cdc2 and Nissl stain-
ing, the interhemispheric ratio of DCx expression was
greater 14 days after tMCAO compared with sham-
operated controls (tMCAO group ratio 2.25 vs control
ratio 1.12, p  0.01, two-tailed t test). In addition to
ischemia-induced increases in DCx expression, we found
similar increases in immunoreactivity for other markers
of SVZ neuroblasts, including PSA-NCAM and neuron-
specific -tubulin (Fig 5D, E and data not shown).
Comparable to the pattern of increased cell proliferation
and enlargement of the SVZ, the expansion of SVZ
neuroblasts after tMCAO occurred in the lateral aspect
of the SVZ but was maximal in the dorsolateral region
(see Fig 4). In some instances when smaller, more local-
ized infarcts (still involving striatum and cortex) occurred,
however, an increase in SVZ neuroblasts appeared focally
in the lateral or inferior aspects of the SVZ adjacent to the
site of injury (see Fig 4F and G). This finding suggested
that lesser degrees of ischemic injury exert a more discrete
effect on SVZ neuronal precursors.
To confirm that the SVZ neuroblasts were newly gen-
erated after tMCAO, we performed immunofluores-
cence double labeling for BrdU and immature neuronal
markers. Confocal optical images were carefully exam-
ined for colocalization of labeling within cells.
As expected, cells in the forebrain SVZ that had in-
corporated BrdU 5 to 7 days earlier also expressed
the neuroblast markers PSA-NCAM, neuron-specific
-tubulin and DCx, in both ipsilateral and contralateral
hemispheres, at 2 weeks after tMCAO (see Fig 5C and
data not shown). To determine whether the SVZ astro-
cyte population also expanded after tMCAO, we immu-
nostained for vimentin and GFAP, intermediate fila-
ment proteins expressed by astrocytes in the SVZ.33,34
Compared with markers of SVZ neuroblasts, expression
of these astrocytic markers was relatively unchanged in
the forebrain SVZ after tMCAO despite markedly in-
creased immunoreactivity in the adjacent striatum of the
infarcted hemisphere (see Fig 5D and E). A similar find-
ing has been reported after seizure-induced injury.22 Neu-
roblasts in the SVZ did not coexpress astrocytic markers
in either the ipsilateral or contralateral hemispheres (see
Fig 5A, D, E). These data indicate that focal infarcts in-
duced by tMCAO relatively selectively stimulate neuro-
genesis in the forebrain SVZ at the time points examined.
Chains of Neuroblasts Extend to Periinfarct Regions
after Stroke
In a previous study, we found that seizure-induced in-
jury altered the migration of SVZ neuroblasts in the
forebrain.22 To determine whether focal ischemic injury
also influences the destinations of SVZ neuroblasts that
normally migrate to the olfactory bulb, we first exam-
ined the pattern of BrdU labeling outside the forebrain
SVZ at various times after tMCAO. At all time points
examined after focal ischemia, BrdU-labeled cells were
found near periinfarct regions in markedly greater num-
bers than in homotopic areas of the uninjured hemi-
sphere or in controls (see Figs 2D, 2E, 3, and 6). The
numbers of BrdU-immunoreactive cells near infarcted
striatum or cortex peaked at 14 days after stroke (see Fig
6B–D and data not shown) and persisted for at least 5
weeks after tMCAO, the latest time point examined (see
Fig 6D and E). We next sought to determine whether
neuroblasts were also present after injury in these regions
that normally do not support neurogenesis. We immu-
nostained for DCx and PSA-NCAM and compared the
expression patterns in the infarcted hemisphere with
those of the contralateral side at 14 to 21 days after
tMCAO. Many DCx-expressing cells with migratory
profiles were present in periinfarct regions outside of the
SVZ but were nearly completely absent in homologous
regions of the noninfarcted hemisphere or in sham-
operated controls (see Fig 4, and data not shown). These
cells appeared at all time points examined after tMCAO
(between 10 and 35 days) and were maximal at 14 days
after the stroke. At this time point, DCx immunostain-
ing was more than 25-fold higher in the injured stria-
tum compared with the contralateral hemisphere (mean
percentage of striatal area immunostained  standard
error of the mean in the ipsilateral hemisphere 0.593 
0.149 vs 0.022  0.01 in the contralateral side; p 
0.03, paired t test). Similar differences were found in the
pattern of striatal PSA-NCAM immunostaining after
stroke (see Fig 5D–F).
We suspected that the cells near injured regions ex-
pressing DCX and other neuroblast markers were im-
mature neurons. These markers, however, occasion-
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ally are expressed by mature neurons putatively
involved in network reorganization.9 To confirm that
these cells were indeed newly generated, we used
BrdU labeling and double-label immunofluorescence
for cell type–specific markers. As expected, many of
the BrdU-labeled cells found outside of the SVZ in
the periinfarct neostriatum 2 to 3 weeks after tM-
CAO (and 5–12 days after the last BrdU injection)
coexpressed the immature neuronal markers DCx,
PSA-NCAM, and MAP2C (see Fig 5G–J). The
double-labeled cells typically exhibited morphologies
consistent with migrating neuroblasts, including elon-
gated cell bodies and bipolar processes. Some BrdU-
immunoreactive cells in the injured striatum also
expressed the endothelial cell marker Glut-1 or, less
frequently, astrocytic (GFAP) or activated microglial
(ED1) markers at 14 to 21 days after tMCAO (data
not shown). The DCx- or PSA-NCAM–immuno-
stained cells in periinfarct regions were confirmed to
be neuronal as they coexpressed neuron-specific
-tubulin or MAP2, but not glial or endothelial cell
markers (see Fig 5B, F, K–M, and data not shown).
DCx-immunoreactive cells sometimes appeared as in-
dividual migratory profiles near infarcted cortex, or in
peculiar cell clusters in the neostriatum in which
many of the cells coexpressed neuronal, but not glial,
markers (see Figs 4B–D and 5L and M). The precise
nature of the cell clusters was uncertain; however,
they were composed predominantly of neurons based
on double labeling, and they appeared to “avoid” the
neostriatal white matter tracts. Interestingly, DCx- or
PSA-NCAM–immunoreactive cells frequently were
observed in chains extending laterally or inferolater-
ally from the SVZ to the injured neostriatum (see
Figs 4 and 5E, F, K). The chains appeared very sim-
ilar to the chains of migrating neuroblasts seen nor-
mally in the rodent RMS. They arose from lateral or
dorsolateral SVZ regions of the infarcted hemisphere
and were typically in close contact with astroctyes,
which were present in markedly increased numbers in
the injured hemisphere (see Fig 5D–F, K). These data
suggest that newly generated neuroblasts migrate from
the SVZ to regions of ischemic brain injury, perhaps
guided by astrocytes activated after injury.
Newly Generated Neurons in the Neostriatum
Differentiate into a Region-appropriate Phenotype
and Persist at Least 5 Weeks after Ischemia
The finding of chains of neuroblasts extending from
the forebrain SVZ to periinfarct regions suggested that
cues induced by focal ischemic injury promote ectopic
neurogenesis in the adult rat forebrain. However,
newly generated neurons are likely to be a useful source
for neuronal replacement after injury only if they are
able to survive and differentiate into neuronal subtypes
appropriate to the injured region. To determine
whether newly generated cells persist near damaged ar-
eas, we first examined BrdU labeling in the injured
hemisphere at 5 weeks after tMCAO. At the 5-week
time point (26 days after the last BrdU injection), we
found BrdU-immunoreactive cells in periinfarct regions
of striatum and cortex (see Fig 6D and E). The num-
ber of BrdU-labeled cells at 5 weeks after stroke was
visibly less than earlier time points (see Fig 6B–E), sug-
gesting that many of the newly generated cells died
over time. It is also possible that cells which previously
incorporated BrdU divided a sufficient number of
times that the BrdU content in their progeny was di-
luted to levels below immunocytochemical detection.
We next sought to determine the phenotypes of the
BrdU-labeled cells that persisted in regions adjacent to
ischemic injury. Immunofluorescence double labeling
was performed at 5 weeks after tMCAO, and confocal
z-series images were collected and carefully examined for
colocalization of labeling within cells. BrdU-labeled cells
near infarcted cortex did not express the neuronal mark-
ers NeuN and MAP2 but occasionally expressed markers
of astrocytic or endothelial lineage cells (data not
Fig 6. 5-Bromodeoxyuridine (BrdU)–labeled cells in the stria-
tum and cortex after focal ischemia. (A, B) BrdU immuno-
staining 2 weeks after occlusion of the right middle cerebral
artery (tMCAO). (C, D) Some BrdU-labeled cells persist in the
periinfarct neostriatum at 21 (C) and 35 (D) days after focal
ischemia. The dorsolateral tip of the subventricular zone (SVZ)
is just outside the upper left of the panels. (E) BrdU-positive
cells in the periinfarct frontal neocortex at 5 weeks after tM-
CAO (arrows point to the infarct border). Lateral is to the
right in B to E. LV  lateral ventricle; il  ipsilateral to
stroke; cl  contralateral to stroke. Scale bar in A  200m
for A and B and 100m for C to E.
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shown). In regions adjacent to infarcted neostriatum 5
weeks after tMCAO, however, a large portion of the
BrdU-labeled cells exhibited neuronal morphologies and
was immunoreactive for the neuronal nuclear antigen
NeuN (see Fig 7A and B). To determine whether these
newly generated neurons expressed a phenotype appro-
priate for their location in the injured neostriatum, we
double-labeled for BrdU and DARPP-32, calbindin
D28k, or parvalbumin. Thirty-five days after tMCAO,
many cells double-labeled for BrdU and DARPP-32 or
calbindin (see Fig 7C and D), markers of neostriatal me-
dium spiny neurons.35,36 No BrdU-immunoreactive
cells expressed parvalbumin (data not shown), a marker
for a subset of striatal interneurons.37 Fewer cells that
had incorporated BrdU expressed GFAP or Glut-1 in
the injured neostriatum (data not shown). We counted
the percentages of BrdU-immunoreactive cells that coex-
pressed cell type–specific markers in confocal z-series
stacks (0.8–1.0m optical slices) from three to five mi-
croscopic fields (63 objective) using two animals killed
35 days after tMCAO. In the periinfarct striatum at 35
days after tMCAO, the percentage of BrdU-labeled cells
that double-labeled for each marker was 70% for
DARPP-32 (52/74 total BrdU-positive cells); 50% for
calbindin-D28k (45/91 cells); 48% for NeuN (32/67
cells); 22% for GFAP (22/101 BrdU-labeled cells); and
16% for Glut-1 (8/49 cells). Most of the neostriatal neu-
rons that incorporated BrdU (see Fig 7) were near the
boundary of the infarct.
We also found DARPP-32 expression in both ipsilat-
eral and contralateral SVZ-olfactory bulb pathways (data
not shown). This finding was unexpected given the pre-
sumed specificity of this marker for striatal projection
neurons.35 At 14 days after tMCAO (5 days after the
last BrdU injection), DARPP-32 expression was not
present in the olfactory bulb granule cell layer in which
most BrdU-labeled cells appeared, suggesting that its ex-
pression declined rapidly as the olfactory bulb neurons
became postmitotic. It is possible that some of the newly
generated, DARPP-32-expressing neurons in the stria-
tum 35 days after tMCAO had not yet differentiated.
This number is probably low, however, given the timing
after BrdU injections and our finding that most of the
cells had a differentiated neuronal morphology. Similar,
albeit lower, percentages of BrdU-labeled cells in stria-
tum also expressed the mature neuronal markers
calbindin-D28k and NeuN (see Fig 7). No DARPP-32
was expressed in injured cortex after stroke (data not
shown). Together, these data indicate that newly gener-
ated neurons persist in the injured neostriatum, where
they appear to differentiate into a region-appropriate
Fig 7. Newly generated neurons persist in the neostriatum after occlusion of the right middle cerebral artery (tMCAO) and differen-
tiate into a region-appropriate phenotype. (A, B) Confocal microscopic images of the periinfarct neostriatum double-labeled for 5-
bromodeoxyuridine (BrdU; red) and NeuN (green). The low-magnification view (A) shows the infarct (asterisk) laterally and the
lateral ventricle (LV) medially. A partial z-series from the boxed region in A is shown in B. Approximately half of the BrdU-
labeled cells coexpress NeuN (arrows), whereas other cells are immunoreactive only for NeuN or BrdU (arrowheads). Many BrdU-
labeled cells (red) from the same periinfarct region (asterisk at the stroke border in C) also coexpress calbindin-D28K (C) or
DARPP-32 (D). Arrowheads point to single-labeled cells. The spacing is 1m between panels in B and D. Scale bar in A 
150m, and in D  10m for B to D.
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neuronal subtype corresponding to the majority of neu-
rons lost in the striatum after tMCAO.
Discussion
This study demonstrates that adult rat forebrain neural
precursors generate neurons with appropriate regional
specificity after stroke. We have found that tMCAO in-
creases SVZ cell proliferation and neurogenesis ipsilateral
to infarcted brain regions, with many SVZ neuroblasts
extending ectopically to sites of injury. Importantly, in
damaged neostriatum, neuroblasts differentiate into cells
that have neuronal morphologies and express markers
specific for medium spiny neostriatal neurons.35,36 If
these new neurons are capable of long-term survival
and integration, then augmentation of endogenous neu-
rogenesis is a plausible strategy for brain regenerative
therapies.
The increase in proliferating SVZ neuroblasts after
focal ischemia may reflect several effects of ischemic in-
jury on neuronal precursors. Increased neurogenesis
can result from accelerated neuroblast proliferation, an
enhancement of neuroblast survival, or a combination
of the two. Although we cannot differentiate between
these possibilities at present, our data indicate that fo-
cal ischemia induces a robust expansion of neuroblast
numbers in the adult rat forebrain SVZ. Our finding
of continued migration of BrdU-labeled SVZ precur-
sors to the olfactory bulb after tMCAO excludes the
possibility that an apparent increase in neurogenesis is
instead caused by an accumulation of neuroblasts that
fail to migrate after ischemic injury. Prior studies also
have found increased cell proliferation and neurogen-
esis in the adult rat forebrain SVZ after focal isch-
emia.25,26 However, in these reports the differentiation
and survival of neuroblasts outside of the SVZ–olfac-
tory bulb pathway was not seen. The reason for the
disparity from our findings may relate to differences in
infarct size25 or the nature of the stroke model used.26
Neural precursors in the SVZ are a potential source of
new neurons after injury. However, dormant progenitors
with neurogenic potential in vitro exist throughout the
adult rodent forebrain.38 The possibility exists that both
sources contribute to the neostriatal neurogenesis that
occurs after tMCAO. Several factors lead us to conclude
that a substantial portion of the newly generated neo-
striatal neurons arise from the forebrain SVZ. First, the
neuroblast population in the SVZ markedly expands af-
ter focal ischemia. Second, most neuroblasts are found
in the striatum close to the SVZ, despite the fact that
more proliferating cells in the intact adult rodent brain
appear in cortex and corpus callosum than in striatum.38
Finally, we found chains of neuroblasts, in close apposi-
tion to astrocytes, extending from the SVZ to the in-
jured striatum after focal ischemia. This structural ar-
rangement is very similar to the chain migration of
neuroblasts through astrocytic tubes characteristic of the
RMS3–5 and suggests that cues induced by ischemic in-
jury may redirect some of the SVZ neuroblasts to mi-
grate into periinfarct brain regions. The ectopic migra-
tion of SVZ neuroblasts into injured forebrain after
prolonged seizures also has been reported recently.22
Our results do not exclude a contribution to ischemia-
induced neostriatal neurogenesis from otherwise “dor-
mant” progenitors outside the SVZ.
The molecular cues underlying ischemia-induced neu-
rogenesis and altered neuroblast migration are unknown.
Cell death may act directly to increase neurogenesis or
induce the differentiation of neurons in ectopic loca-
tions.39–42 The targeted induction of focal apoptosis in
adult songbird brain increases neurogenesis,41 and in
adult mouse neocortex it induces neuronal production
in this otherwise dormant brain region.42 These effects
may relate to trophic molecules released by neighboring
cells.43 Because a portion of neuronal death after isch-
emia occurs via apoptotic pathways,44,45 a similar mech-
anism may act to stimulate neurogenesis after experi-
mental stroke. Focal ischemia also induces a marked
astrocyte proliferation (see Fig 5E), and there is evidence
that astrocytes can stimulate adult rodent SVZ neural
precursor proliferation in vitro.46 The activation of as-
trocytes after injury also may underlie the ectopic migra-
tion of SVZ neuroblasts toward damaged brain regions
because a glial-derived factor can increase the migration
rate of neuroblasts in explant cultures of the neonatal rat
SVZ–olfactory bulb pathway.47
As expected, we found markedly increased numbers of
astrocytes in brain regions near the ischemic injury.
Chains of neuroblasts extending ectopically from the
SVZ into the neostriatum after tMCAO were in close
contact with astrocytes (see Fig 5E, F, K). This struc-
tural arrangement suggests that activated astrocytes may
induce or guide the migration of SVZ neuroblasts to
injury, similar to findings of astrocyte activation and al-
tered neuronal precursor migration in the SVZ–olfactory
bulb pathway after seizure-induced injury or transection
lesions of the RMS.22,48 Importantly, the modulation of
SVZ neuroblast proliferation or migration by glia (in-
cluding astrocytes and microglia) may explain why di-
verse brain insults exert similar effects on SVZ neural
precursors.
The injured striatum supported the neuronal differ-
entiation of SVZ precursors after ischemic injury. The
only other report of injury-induced striatal neurogen-
esis in adult rat, after 6-hydroxydopamine lesions of
the nigrostriatal pathway, required the simultaneous
administration of transforming growth factor–.21
Adult striatal neurogenesis also occurred after exoge-
nous brain-derived neurotrophic factor (BDNF) intra-
ventricular infusion or adenoviral-mediated expression
of BDNF in ependyma.49,50 However, BDNF did not
induce substantial neocortical neurogenesis in these
studies. Focal ischemia has been shown to increase the
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expression of BDNF and other growth or neurotrophic
factors in adult rat cortex or neostriatum near the ros-
tral SVZ or RMS.51–56 In some instances, increased
expression is sustained for up to 14 days, similar to the
temporal pattern of ischemia-induced neurogenesis and
neuroblast migration described herein. As with in-
creased BDNF expression, proliferating cells in injured
cortex failed to differentiate into neurons after focal
ischemia. Together, these findings suggest that the in-
jured cortex is a nonpermissive environment for neu-
ronal differentiation, either because of lack of instruc-
tive or survival cues or the presence of signals
inhibitory for neurogenesis.
Stroke is a devastating neurological disorder, and
those that experience cerebral infarcts show varying de-
grees of recovery. Existing evidence suggests that syn-
aptic reorganization and activation of ipsilateral path-
ways are important for functional improvement (for
reviews see Hallett57 and Rijntjes and Weiller58). How-
ever, our finding of ischemia-induced neuronal recruit-
ment in the adult mammalian forebrain offers a new
perspective on plasticity and the potential for neuronal
replacement after brain injury. The marked extent of
ectopic forebrain neurogenesis in the first few weeks
after ischemic injury suggests that a large capacity for
self-repair persists in adult rodent brain. Our data and
the work of others26 indicate that many of these neu-
roblasts fail to survive after focal ischemic injury. Al-
though augmentation of neurogenesis, including neu-
ronal differentiation and survival, awaits a better
understanding of neural stem cell biology, such manip-
ulations eventually may lead to novel strategies to im-
prove recovery after stroke. The functional integration
of newly generated neurons in the neostriatum is a key
issue that remains to be determined. Recent studies of
focally induced apoptosis in adult mouse neocortex in-
dicate that some newly generated neurons in the adult
are able to survive for prolonged periods and send ap-
propriate long-distance projections.42 Therefore, inte-
gration of new neurons into mature networks after
brain injury is possible.
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